Dow Down1.60% Nasdaq Down0.39%

Eli Lilly and Company (LLY)

-NYSE
71.42 Down 1.65(2.26%) 4:03PM EST
|After Hours : 71.44 Up 0.02 (0.03%) 6:09PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 19,615,600   23,113,100   22,603,400  
Cost of Revenue4,932,500  4,908,100  4,796,500  
Gross Profit 14,683,100   18,205,000   17,806,900  
Operating Expenses
Research Development4,733,600  5,531,300  5,278,100  
Selling General and Administrative6,280,300  6,606,700  6,839,500  
Non Recurring668,900  177,700  281,100  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 3,000,300   5,889,300   5,408,200  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes3,000,300  5,889,300  5,408,200  
Interest Expense -   -   -  
Income Before Tax3,000,300  5,889,300  5,408,200  
Income Tax Expense609,800  1,204,500  1,319,600  
Minority Interest -   -   -  
Net Income From Continuing Ops2,390,500  4,684,800  4,088,600  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 2,390,500   4,684,800   4,088,600  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 2,390,500   4,684,800   4,088,600  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.